logo-loader
viewImricor Medical Systems Ltd

Imricor Medical Systems with Proactive at ASX Small and Mid-Cap Conference

Imricor Medical Systems Inc (ASX:IMR) chair and CEO Steve Wedan speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020.  

The company is a leading developer of MRI-compatible medical devices which can be used to carry out MRI-guided cardiac catheter ablation procedures.

Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac catheter ablation procedures.

Quick facts: Imricor Medical Systems Ltd

Price: 2.25 AUD

ASX:IMR
Market: ASX
Market Cap: $253.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Oracle Power CEO explains delay of LOI for Thar Block VI project plan

Oracle Power's (LON:ORCP) CEO Naheed Memon gives her response to the level of activity amongst investors surrounding the status of the 'Letter of Intent' for the Thar Block VI Project. Memon explains the LOI was applied for in March – shortly before the pandemic – and whilst Oracle originally...

30 minutes ago

2 min read